171 related articles for article (PubMed ID: 17157892)
1. A genetically engineered live-attenuated simian-human immunodeficiency virus that co-expresses the RANTES gene improves the magnitude of cellular immunity in rhesus macaques.
Shimizu Y; Inaba K; Kaneyasu K; Ibuki K; Himeno A; Okoba M; Goto Y; Hayami M; Miura T; Haga T
Virology; 2007 Apr; 361(1):68-79. PubMed ID: 17157892
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
Shimizu Y; Miyazaki Y; Ibuki K; Suzuki H; Kaneyasu K; Goto Y; Hayami M; Miura T; Haga T
Virology; 2005 Dec; 343(2):151-61. PubMed ID: 16169034
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma.
Iida T; Kuwata T; Ui M; Suzuki H; Miura T; Ibuki K; Takahashi H; Yamamoto T; Imanishi J; Hayami M; Kita M
Arch Virol; 2004 Apr; 149(4):743-57. PubMed ID: 15045561
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
5. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
6. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs.
Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M
Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597
[TBL] [Abstract][Full Text] [Related]
7. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
[TBL] [Abstract][Full Text] [Related]
8. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
Liu ZQ; Muhkerjee S; Sahni M; McCormick-Davis C; Leung K; Li Z; Gattone VH; Tian C; Doms RW; Hoffman TL; Raghavan R; Narayan O; Stephens EB
Virology; 1999 Aug; 260(2):295-307. PubMed ID: 10417264
[TBL] [Abstract][Full Text] [Related]
9. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
[TBL] [Abstract][Full Text] [Related]
10. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
12. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.
Singh DK; McCormick C; Pacyniak E; Lawrence K; Dalton SB; Pinson DM; Sun F; Berman NE; Calvert M; Gunderson RS; Wong SW; Stephens EB
Virology; 2001 Mar; 282(1):123-40. PubMed ID: 11259196
[TBL] [Abstract][Full Text] [Related]
13. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques.
Villinger F; Switzer WM; Parekh BS; Otten RA; Adams D; Shanmugam V; Bostik P; Mayne AE; Chikkala NF; McClure HM; Novembre F; Yao Q; Heneine W; Folks TM; Ansari AA
Virology; 2000 Dec; 278(1):194-206. PubMed ID: 11112494
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
Kaneyasu K; Kita M; Ohkura S; Yamamoto T; Ibuki K; Enose Y; Sato A; Kodama M; Miura T; Hayami M
Microbiol Immunol; 2005; 49(12):1083-94. PubMed ID: 16365534
[TBL] [Abstract][Full Text] [Related]
15. Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.
Zhan X; Martin LN; Slobod KS; Coleclough C; Lockey TD; Brown SA; Stambas J; Bonsignori M; Sealy RE; Blanchard JL; Hurwitz JL
Vaccine; 2005 Nov; 23(46-47):5306-20. PubMed ID: 16095768
[TBL] [Abstract][Full Text] [Related]
16. Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques.
Mackay GA; Niu Y; Liu ZQ; Mukherjee S; Li Z; Adany I; Buch S; Zhuge W; McClure HM; Narayan O; Smith MS
Virology; 2002 Mar; 295(1):133-46. PubMed ID: 12033772
[TBL] [Abstract][Full Text] [Related]
17. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
[TBL] [Abstract][Full Text] [Related]
18. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the relative therapeutic effects of vaccines on virus load and immune responses in small groups at several time points: efficacy of mucosal and subcutaneous polypeptide vaccines in rhesus macaques exposed to SHIV.
Kuznetsov VA; Stepanov VS; Berzofsky JA; Belyakov IM
J Clin Virol; 2004 Dec; 31 Suppl 1():S69-82. PubMed ID: 15567097
[TBL] [Abstract][Full Text] [Related]
20. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
Kumar R; Orsoni S; Norman L; Verma AS; Tirado G; Giavedoni LD; Staprans S; Miller GM; Buch SJ; Kumar A
Virology; 2006 Oct; 354(1):192-206. PubMed ID: 16876224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
